Ratings
0
Nobody has rated this yet. Be the first!
Works
4
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
Novel methods to diagnose leptomeningeal metastases in breast cancer
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.
